Generic name:cemiplimab-rwlc [ se-MIP-li-mab ]
Drug class:Anti-PD-1 monoclonal antibodies
What is Libtayo?
Libtayo is a medicine used to treat skin cancer by working with your immune system.
Libtayo is used to treat a certain type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread to other parts of the body or cannot be treated with radiation or surgery.
Libtayo is used to treat a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced BCC), or has spread to other parts of the body (metastatic BCC), and you have received treatment with a hedgehog pathway inhibitor (HHI), or if you cannot receive treatment with a HHI.
Libtayo is also used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) as a first treatment when the cancer has not spread outside the chest (locally advanced NSCLC) and you cannot have surgery or chemotherapy with radiation, or when the cancer has spread to other areas of the body (metastatic NSCLC) and the tumor tests positive for high "PD-L1" and does not have an abnormal "EGFR", "ALK" or "ROS1" gene.
Libtayo can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. These problems may happen anytime during treatment or even after your treatment has ended.
Warnings
Libtayo strengthens your immune system to help your body fight against cancer cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, you may develop serious or life-threatening medical...
